Lunai Bioworks Advances AI Chemical Risk Screening
Sacramento, California, U.S., September 16, 2026 Lunai Bioworks, Inc. has announced results from a technical case study demonstrating an...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Sacramento, California, U.S., September 16, 2026 Lunai Bioworks, Inc. has announced results from a technical case study demonstrating an...
Miami, Florida, USA, September 16, 2026 Synergy Spine Solutions® has highlighted new two-year clinical outcomes for its FDA-approved Synergy...
